Renovascular hypertension (RVH) is a low prevalence and curable disease.
RVH(肾血管性高血压)是一种低发性，可治性疾病。
METHODS The renovascular hypertension model was induced in rats by two-kidney-one-clip method.
方法采用两肾一夹型肾血管性高血压大鼠模型。
Renovascular hypertension (RVH) is a disease with low prevalence which is below 1% in hypertension.
肾血管性高血压(RVH)是一种发病率较低的疾病，在高血压中不到1%。
Methods Two kidney 1 clip (2K1C) rats were used to reestablish the model of renovascular hypertension.
方法：建立二肾一夹（2K1C）肾血管性高血压大鼠模型。
Objective To investigate the effect of taurine on cardiomyocyte apoptosis in the rats with renovascular hypertension.
目的：探讨牛磺酸对高血压大鼠左室心肌细胞凋亡的影响。
Secondary hypertension comprised 51.3% of endocrine hypertension, 24.8% of renovascular hypertension (RVH)and 22.3% of renal hypertension.
在继发性高血压中，内分泌性高血压占51·3%，肾血管性高血压占24·8%； 肾性高血压占22·3%。
Objective To investigate the role of L-arginine on renin-angiotensin system(RAS) in cardiovascular tissue of rats with renovascular hypertension.
目的探讨一氧化氮前体L-精氨酸对肾血管性高血压大鼠心血管组织局部肾素-血管紧张素系统（RAS）的影响。
Objective: To evaluate the primary and clinical efficacy of percutaneous transluminal angioplasty and stenting in patients with renovascular hypertension of renal artery stenoses.
目的：评估肾动脉狭窄所致高血压介入治疗的临床疗效。
Objective: To evaluate the primary and clinical efficacy of percutaneous transluminal angioplasty and stenting in patients with renovascular hypertension of renal artery stenoses.
目的：评估肾动脉狭窄所致高血压介入治疗的临床疗效。
应用推荐